| [1] | Manpreet, J., Ramanjit, K. & Seema, S. 2018. Scientific Cultivation of Ginger (Zingiber officinalis). In book: Advances in Vegetable Agronomy 191-197. |
| |
| [2] | Rakhi Nair, V., Boby Johns, G., Daisy, P., A., Praveen, R., Noby, T., Jenny, S. & Betty, C. 2017.A review on the anti-diabetic properties of ginger. World J of pharmacy and pharma sci 6(4): 197-206. |
| |
| [3] | Kusumarn, N. & Putrada, N.A. 2018. Antidiabetic Activity of Zingiber officinale Roscoe Rhizome Extract: an In Vitro Study Hayati. Jou of Biosci 25(4): 160-168. |
| |
| [4] | Bi, X., Lim., J., Henry, C., J. 2017. Spices in the management of diabetes mellitus. Food Chem 217: 281-293. |
| |
| [5] | Son, M., J., Miura, Y. & Yagasaki, K. 2015. Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice. Cytotechnology 67: 641-652. |
| |
| [6] | Niss, F., Rosenmai, A.,K., Mandava, G., Orn, S., Oskarsson, A. & Lundqvist, J. 2018. Toxicity bioassays with concentrated cell culture media a methodology to overcome the chemical loss by conventional preparation of water samples. Environ Sci Pollut Res 25: 12183-12188. |
| |
| [7] | Nafiseh, K., Farzad, S., Asadollah, R., Tayebeh, R., Payam, H. & Mohsen, M.T. 2015.The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, Apolipoprotein B, Apolipoprotein A-I and Malondialdehyde in Type 2 Diabetic Patients. Iranian Jou of Pharma Res 14 (1): 131-140. |
| |
| [8] | James, W., D., Mini, Y., Da, S.K. & Sunmin, P. 2015. Efficacy of ginger for treating Type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials. J of Ethnic Foods 2 (5): 36-43. |
| |
| [9] | Qian-Qian, M., Xiao-Yu, X., Shi-Yu, C., Ren-You, G., Harold, C., Trust, B. & Hua-Bin, L. 2019. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods 8(6): 1-21. |
| |
| [10] | Zhang, F., Thakur, K., Hu, F., Zhang, J.G. & Wei, Z.J. 2017. Cross talk between 10- gingerol and its anti- cancerous potential: a recent update. Food Funct 8: 2635-2649. |
| |
| [11] | Hany, K.,K.,M., Ghada, G.H. & Dalia Alaa, E.A.E. 2017. The possible protective role of 6-gingerol on a model of hepatic injury induced by carbon tetrachloride in adult male albino rats. Histological and immunohistochemical study 40(3): 499-511. |
| |
| [12] | Saleh, I.A. 2009. Quantification of 6-gingerol in Zingiber officinale extract, ginger-containing dietary supplements, teas and commercial creams by validated HPTLC densitometry. FABAD J Pharm Sci 34: 33-42. |
| |
| [13] | Puengphian, C. & Sirichote, A. 2008. 6-gingerol content and bioactive properties of ginger (Zingiber officinale Roscoe) extracts from supercritical CO2 extraction. As J Food Ag- Ind 1 (1): 29-36. |
| |
| [14] | Ali Ghasemzadeh., Hawa, Z., E., F., Ali, B. & Amin, T.M. 2018.Tayebi-Meigooni. Formation of 6-, 8- and 10-Shogaol in Ginger through Application of Different Drying Methods: Altered Antioxidant and Antimicrobial Activity. Molecules 23(7): 1646. |
| |
| [15] | Aeschbach, R., Loliger, J., Scott, B., C., Murcia, A., Halliwell, J.B. & Aruoma, O. 2014. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol 32(1): 31-36. |
| |
| [16] | Park, J.S. & Jung, M.Y. 2012. Development of high-performance liquid chromatography-time-of-flight mass spectrometry for the simultaneous characterization and quantitative analysis of gingerol-related compounds in ginger products. J Agric Food Chem 60: 10015-10026. |
| |
| [17] | Zhang, X., Iwaoka, W., T., Huang, A., S., Nakamoto, S.T. & Wong, R. 1994. Gingerol Decreases after Processing and Storage of Ginger. J of Food Sci 59(6): 1338-1340. |
| |
| [18] | Guo, J., B., Zhang, W., J., Wu, H. & Du. L.M. 2015. Microwave-assisted decomposition coupled with acidic food condiment as an efficient technology for ginger (Zingiber officinale Roscoe). Sep Purif Technol 146: 219-226. |
| |
| [19] | Ito, S., Ohmi, A., Sakamiya, A., Yano, T., Okumura, K., Nishimura, N. & Kagontani, K. 2016. Ginger hexane extract suppresses RANKL-induced osteoclast differentiation. BioSci Biotechnol Biochem 80: 779-785. |
| |
| [20] | Anisa, N., I., Azian, N., Sharizan, M. & Iwai, Y. 2014. Temperature effects on diffusion coefficient for 6-gingerol and 6-shogaol in sub critical water extraction. J Phys Conf Ser 495: 1-6. |
| |
| [21] | Chen, C., C., Kuo, M., C., Wu, C.M. & Ho, C.T. 1986b. Pungent compounds of ginger (Zingiber officinale Roscoe) extracted by liquid carbon dioxide. JournalofAgri & Food Chem 34: 477-480. |
| |
| [22] | Hiserodt, R., D., Franzblau, S.G. & Rosen, R.T. 1998. Isolation of 6-, 8-, and 10-gingerol from ginger rhizome by HPLC and preliminary evaluation of inhibition of Mycobacterium avium and Mycobacterium tuberculosis. Journalof Agri & Food Chem 46: 2504-2508. |
| |
| [23] | Murthy, P., S., Guatam, R. & Naik, P.J. 2015. Ginger oleoresin chemical composition, bioactivity and application as bio-preservatives. J Food Proc Pres 39: 1905-1912. |
| |
| [24] | Naghia, P.T. 2013. Ginger (Zingiber officinale Roscoe) Oleoresin Extraction with Supercritical CO2: Effect of Flow Rate, Co-solvent and Microwave Treatment. BS Thesis School of Biotechnology Int Univ Hochiminh Vietnam 32. |
| |
| [25] | MdSarip, M., S., Morad, N., A., Mohamad, A., N., A., MohdYusof, Y.A. & CheYunus, M.A. 2014. The kinetics of extraction of the medicinal ginger bioactive compounds using hot compressed water. separation and Purification Technology 124: 141-147. |
| |
| [26] | Bartley, J.P. 1995. A new method for the determination of pungent compounds in ginger (Zingiber officinale). Journal of the Sci of Food & Agri 68: 215-222. |
| |
| [27] | Azian, M., N., Ilia Anisa, A.N. & Iwai, Y. 2014. Mechanisms of Ginger Bioactive Compounds Extract Using Soxhlet and Accelerated Water Extraction. Int J of Chem and Mol Eng 8(5): 358-362. |
| |
| [28] | Awang, M., A., Azelan, N., A., Aqilla, W.,M.,N.,A., Aziz, R.A. & Hasham, R. 2014. Influence of processing parameters on the yield and 6-gingerol content of Zingiber officinale extract. J of Chem and Pharma Res 6(11): 358-363. |
| |
| [29] | Hans Wohlmuth. 2008. Phytochemistry and Pharmacology of plants from the ginger family, Zingiberaceae., Department of Natural and Complementary Medicine. Southern Cross University Lismore Australia. |
| |
| [30] | Zhan, K., Xu, K. & Yin, H. 2011. Preparative separation and purification of gingerols from ginger (Zingiber officinale Roscoe) by high-speed counter-current chromatography. Food Chem 126: 1959-1963. |
| |
| [31] | Wang, Z., Hasegawa, J., Wang, X. & Watanabe, T. 2011. Protective effects of ginger against aspirin-induced gastric ulcers in rats. Yonago Acta Medica 54: 11-19. |
| |
| [32] | Theeraphan Chumroenphan., Issaraporn, S., Luchai, B. & Surapon, S. 2018. Saensouk. 6-gingerol content of ginger (Zingiber officinale Roscoe) by different drying methods. sciencesconf. org:botatropasia 78898. |
| |
| [33] | Jayashree, E., Visvanathan, R. & John Z.T. 2014. Quality of dry ginger (Zingiber officinale) by different drying methods. J Food Sci Technol 51(11): 3190-3198. |
| |
| [34] | Tanweer, S., Mehmood, T., Zainab, S., Ahmad, Z. & Shehzad, A. 2020. Comparison and HPLC quantification of antioxidant profiling of ginger rhizome, leaves and flower extracts. Clinical Phytoscience 6(12). |
| |
| [35] | Usama, I.,A., Mohamed, S.,A., Hussein, S.T. & El-Sayed, I. 2013. Characterization of 6-Gingerol for In Vivo and In Vitro Ginger (Zingiber officinale) Using High Performance Liquid Chromatography. Global J of Bot Sci 1(9): 9-17. |
| |
| [36] | Sunghun Cho., Dong, GL., Sullim, L., Sungwook, C. & Sanghyun, L. 2015. Analysis of the 6-gingerol Content in Zingiber spp., and their Commercial Foods using HPLC. J Appl Biol Chem 58(4): 377-381. |
| |
| [37] | Zhu, J., Chen, H., Song, Z., Wang, X. & Sun, Z. 2018. Effects of Ginger (Zingiber officinale Roscoe) on Type 2 Diabetes Mellitus and Components of the Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 5692962. |
| |
| [38] | Mohammed, A., Gbonjubola, V., A., Koorbanally, N.A. & Islam, M.S. 2017. Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruit. Pharm Biol 55: 1010-1016. |
| |
| [39] | Mohammed, A. & Islam, M.S. 2018. Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus. Front Pharmacol 9: 893. |
| |
| [40] | Chung, M., Y., Choi, H.K. & Hwang, J.T. 2021. AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals. Nutrients 13: 4050. |
| |
| [41] | El-Bassossy, H., M., Elberry, A., A., Ghareib, S., A., Azhar, A., Banjar, Z.M. & Watson, M.L. 2016. Cardioprotection by 6-gingerol in diabetic rats. Biochem and Biophy Res Comm 477(4): 908-914. |
| |
| [42] | Lee, J., O., Kim, N., Lee, H., J., Moon, J.,W., Lee, S.,K., Kim, S., J., Kim, J., K., Park, S.H. & Kim, H.S. 2015. [6]-Gingerol affects glucose metabolism by dual regulation via the AMPKa2- mediated AS160-Rab5 pathway and AMPK-mediated insulin sensitizing effects. J Cell Biochem 11: 1401-1410. |
| |
| [43] | Li, X., Guo, J., Liang, N., Jiang, X., Song, Y., Ou, S., Hu, Y., Jiao, R. & Bai, W. 2018. 6-Gingerol Regulates Hepatic Cholesterol Metabolism by Up-regulation of LDLR and Cholesterol Efflux-Related Genes in HepG2 Cells. Front Pharmacol 9: 159. |
| |
| [44] | Lei, L., Liu, Y., Wang, X., Jiao, R., Ma, K.Y. & Li, Y.M. 2014. Plasma cholesterol-lowering activity of gingerol and shogaol-enriched extract is mediated by increasing sterol excretion. J Agric Food Chem 62: 10515-10521. |
| |
| [45] | Park, K.,K., Chun, KS., Lee, JM., Lee, S.S. & Surh, YJ. 1998. Inhibitory effect of [6]-gingerol, a major pungent principle of ginger on Phorbol ester- induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer letters 129: 139-144. |
| |
| [46] | Tzeng, T., F., Chang, C.J. & Liu, I.M. 2014. 6-Gingerol inhibits rosiglitazone induced adipogenesis in 3T3-L1 adipocytes. Phytother Res 28: 187-192. |
| |
| [47] | Isa, Y., Miyakawa, Y., Yanagisawa, M., Goto, T., Kang, M., S., Kawada, T., Morimitsu, Y., Kubota, K, & Tsuda, T. 2008. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem BiophysRes Comm 373: 429-434. |
| |
| [48] | Shao, Y., Yu, Y., Li, C., Yu, J., Zong, R. & Pei, C. 2016. Synergistic effect of quercetin and 6-gingerol treatment in streptozotocin induced type 2 diabetic rats and poloxamer P-407 induced hyperlipidemia. RSC Adv 6: 12235-12242. |
| |
| [49] | Alqasoumi, S., Yusufoglu, H., Farraj, A. & Alam, A. 2011. Effect of 6-shogaol and 6-gingerol on Diclofenac Sodium Induced Liver Injury. Int J Pharmacol 7: 868-873. |
| |
| [50] | Al-Azhary, D.B. 2011. Ginger enhances antioxidant activity and attenuates atherogenesis in diabetic cholesterol-fed rats. Aust J Basic Appl Sci 5: 2150-2158. |
| |
| [51] | Singh, A.,B.,A., Singh, N., Maurya, R. & Srivastava, A.K. 2009. Anti-hyperglycaemic, lipid lowering and antioxidant properties of 6-gingerol in db/db mice. Int J of Med and Med Sci 1(12): 536-544. |
| |
| [52] | Sukalingam, K., Ganesan, K. & Sharmila, B. 2013. Hypoglycemic Effect of 6-Gingerol, an Active Principle of Ginger in Streptozotocin Induced Diabetic Rats. J of Pharma and Toxicol Studies 1(2): 33-37. |
| |
| [53] | Sampath, C., Rashid, M., R., Sang, S. & Ahmedna, M. 2017. Specific bioactive compounds in ginger and apple alleviate hyperglycemia in mice with high fat diet-induced obesity via Nrf2 mediated pathway. Food Chem 226: 79-88. |
| |
| [54] | Chakraborty, D., Mukherjee, A., Sikdar, S., Paul, A., Ghosh, S. & Khuda-Bukhsh, A.R. 2012. 6-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxcol Lett 210(11): 34-43. |
| |
| [55] | Dongare, S., Gupta, S.K. & Mathur, R. 2016. Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms. Mol Vis 22: 599-609. |
| |
| [56] | Neumann, D. 2018. Is TAK1 a direct upstream kinase of AMPK?. Int Jof Mol Sci. 19(8). 2412. |
| |
| [57] | Dunn, D.M. & Munger, J. 2020. Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection. Front Cell Infect Microbiol 10: 384. |
| |
| [58] | Curry, D.,W., Stutz, B., Zane, B., Andrews, Z.B. & Elswortha, J.D. 2018. Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease. J of Parkinson’s Dis 8. 161-181. |
| |
| [59] | Yuan, J., Dong, X., Yap, J. & Hu, J. 2020. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J of Hemato & Onco 13: 113. |
| |
| [60] | Grahame Hardie, D. 2013. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62: 2164-2172. |
| |
| [61] | Joungmok Kim., Goowon, Y., Yeji, K., Jin, K. & Joohun, H. 2016. AMPK activators: mechanisms of action and physiological activities. Exp Fabiola Marín-Aguilar Mol Med 48(4): e224. |
| |
| [62] | Shukal, D.,K., Malaviya, P.B. & Sharma, T. 2022. Role of the AMPK signalling pathway in the aetiopathogenesis of ocular diseases. Human and Experi Toxicol 41: 1-28. |
| |
| [63] | Cameron, K.O. & Kurumbail, R.G. 2016. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators. Bioorg Med Chem Lett 26: 5139-5148. |
| |
| [64] | Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., Fakhri, F., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., Zarrabi, A., NuriErtas, Y., Mirzaei, S. & Samarghandian, S. 2022. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomed & Pharmaco therapy 146: 112563. |
| |
| [65] | Ruderman, N., B., Carling, D., Prentki, M. & Cacicedo, J.M. 2013. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123(7): 2764-2772. |
| |
| [66] | Srivastava, R., A., K., Pinkosky, S., L., Filippov, S., Hanselman, J.,C., Cramer, C.T. & Newton, R.S. 2012. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J Lipid Res 53(12): 2490-2514. |
| |
| [67] | Lin, S.C. & Hardie, D.G. 2018. AMPK: Sensing Glucose as well as Cellular Energy Status. Cell Metab 27: 299-313. |
| |
| [68] | Ziegler, N., Raichur, S., Brunner, B., Hemmann, U., Stolte, M., Schwahn, U., Prochnow, H., Weidmann, C., M., Tennagels, N., Margerie, D., Wohlfart, P. & Bielohuby, M. 2020. Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice. Front Endocrinol., (Lausanne) 11: 598. |
| |
| [69] | Bhutta, M., S., Gallo, E.S. & Borenstein, R. 2021. Multifaceted Role of AMPK in Viral Infections. Cells 10(5): 1118. |
| |
| [70] | Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.,R.,F., Kool, M., Agnihotri, S., El-Naggar, A., Yu, B., Somasekharan SP, Faubert B., Bridon, G., Tongon, C.,E., Mathers, J., Thomas, R., Li, A., Barokas, A., Kwok, B., Bowden, M., Smith, S., Wu, X., Korshunov, A., Thomas, H., Northcott, P.,A., Galpin, J.,D., Ahern, C.,A., Wang, Y., McCabe, M., G., Collins, V.,P., Jones, R.,G., Pollak, M., Delattre, O., Gleave, M., E., Jan, E., Pfister, S.,M., Christopher, G.,P., Derry, W., B., Taylor, M.D. & Sorensen, P.H. 2013. The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation. Cell 153: 1064-1079. |
| |
| [71] | Algandaby, M., M., El-Halawany, A., M., Abdallah, H.,M., Alahdal, A.,M., Nagy, A.,A., Ashour, O.M. & Abdel-Naim, A.B. 2016. Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators. Naunyn-Schmiedeberg's Arch Pharmacol 389(4): 419-428. |
| |
| [72] | Shrivastava, S. 2015. The influence of gingerol treatment on aluminium toxicity in rats. J Environ Pathol Toxicol Oncol 34 (1): 11-21. |
| |
| [73] | Grahame Hardie, D. 2016. Regulation of AMP-activated protein kinase by natural and synthetic activators. Acta Pharmaceutica Sinica B 6(1): 1-19. |
| |
| [74] | Steinberg, G.R. & Carling, D. 2019. AMP-activated protein kinase: the current landscape for drug development. Nat Rev Drug Discov 18: 527-551. |
| |
| [75] | Fentz, J., Kjobsted, R., Birk, J.,B., Jordy, A.,B., Jeppesen, J., Thorsen, K., Schjerling, P., Kiens, B., Jessen, N., Viollet, B. & Wojtaszewski, J.F.P. 2015. AMPKα is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice. FASEB J 29(5): 1725-1738. |
| |
| [76] | Garcia, D. & Shaw, R.J. 2017. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell 66(6): 789-800. |
| |